Literature DB >> 8095262

A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model.

P Samama1, S Cotecchia, T Costa, R J Lefkowitz.   

Abstract

We have replaced the C-terminal portion of the third intracellular loop of the beta 2-adrenergic receptor (residues 266-272) with the homologous region of the alpha 1B-adrenergic receptor. In a fashion analogous to the reciprocal mutations of the alpha 1B receptor previously described (Cotecchia, S., Exum, S., Caron, M. G., and Lefkowitz, R. J. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 2896-2900), this conservative substitution leads to agonist-independent activation of adenylyl cyclase. In addition, the constitutively active mutant receptor exhibits: (i) an increased affinity for agonists (even in the absence of guanine nucleotide-binding regulatory protein (G protein)) but not antagonists, with the extent of affinity increase being correlated with the intrinsic activity of the ligand; (ii) an increased potency of agonists for stimulation of adenylyl cyclase; and (iii) an increased intrinsic activity of partial agonists. We document that our experimental findings with the mutant receptor cannot be adequately rationalized within the theoretical framework of the Ternary Complex Model (De Lean, A., Stadel, J. M., and Lefkowitz, R. J. (1980) J. Biol. Chem. 255, 7108-7117) which postulates that receptor activation requires the agonist-promoted formation of an active, "ternary" complex of agonist, receptor, and G protein. We show, through extensive computer simulations, that an extended version of this model that includes an explicit isomerization of the receptor (R) to an active state (R*) closely models all our findings for both the mutant and the wild-type receptors. Study of such constitutively active mutant G protein-coupled receptors should help elucidate the molecular nature of the processes involved in receptor activation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095262

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  245 in total

1.  Constitutively active mutants of 5-HT4 receptors are they in unique active states?

Authors:  S Claeysen; M Sebben; C Bécamel; M L Parmentier; A Dumuis; J Bockaert
Journal:  EMBO Rep       Date:  2001-01       Impact factor: 8.807

Review 2.  Naturally occurring mutations of the luteinizing-hormone receptor: lessons learned about reproductive physiology and G protein-coupled receptors.

Authors:  A C Latronico; D L Segaloff
Journal:  Am J Hum Genet       Date:  1999-10       Impact factor: 11.025

3.  Systematic identification of mutations that constitutively activate the angiotensin II type 1A receptor by screening a randomly mutated cDNA library with an original pharmacological bioassay.

Authors:  C Parnot; S Bardin; S Miserey-Lenkei; D Guedin; P Corvol; E Clauser
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

Review 4.  Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery.

Authors:  R A de Ligt; A P Kourounakis; A P IJzerman
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

5.  Agonist binding to G-protein coupled receptors.

Authors:  P G Strange
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

6.  Signal transfer from rhodopsin to the G-protein: evidence for a two-site sequential fit mechanism.

Authors:  O G Kisselev; C K Meyer; M Heck; O P Ernst; K P Hofmann
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

7.  The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects.

Authors:  Kurt A Krobert; Finn Olav Levy
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

8.  Detection of receptor ligands by monitoring selective stabilization of a Renilla luciferase-tagged, constitutively active mutant, G-protein-coupled receptor.

Authors:  D Ramsay; N Bevan; S Rees; G Milligan
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

9.  Constitutive activation of A(3) adenosine receptors by site-directed mutagenesis.

Authors:  A Chen; Z G Gao; D Barak; B T Liang; K A Jacobson
Journal:  Biochem Biophys Res Commun       Date:  2001-06-15       Impact factor: 3.575

10.  Non-competitive antagonism of beta(2)-agonist-mediated cyclic AMP accumulation by ICI 118551 in BC3H1 cells endogenously expressing constitutively active beta(2)-adrenoceptors.

Authors:  H E Hopkinson; M L Latif; S J Hill
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.